Cooper Companies | COO - Net Income

Stock Price
64.42
Daily Change
-0.53 -0.82%
Monthly
-9.84%
Yearly
-20.36%
Q2 Forecast
63.04

Cooper Companies reported $130.8M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Abbott USD 1.08B 699M Mar/2026
Align Technology USD 135.76M 79.01M Dec/2025
AtriCure USD 1.76M 2.02M Dec/2025
Avanos Medical USD -1.3M 100K Dec/2025
Bausch Health Companies USD -112M 291M Dec/2025
Baxter International USD -1.13B 1.08B Dec/2025
Bayer EUR -3.76B 2.79B Dec/2025
Becton, Dickinson and Co. USD 382M 111M Dec/2025
Boston Scientific USD 672M 83M Dec/2025
Cooper Companies USD 130.8M 46.2M Dec/2025
Dentsply International USD -146M 281M Dec/2025
Dexcom USD 267.3M 16.5M Dec/2025
Edwards Lifesciences USD 380.7M 289.5M Mar/2026
Globus Medical USD 140.59M 21.63M Dec/2025
Haemonetics USD 44.74M 6.06M Dec/2025
Inogen USD -5.96M 373K Sep/2024
Insulet USD 101.6M 14M Dec/2025
Integra LifeSciences USD -1.7M 3.7M Dec/2025
Intuitive Surgical USD 821.5M 26.7M Mar/2026
J&J USD 5.24B 119M Mar/2026
Medtronic USD 1.14B 231M Dec/2025
Merit Medical Systems USD 27.76M 4.83M Sep/2025
Novartis USD 2.41B 1.52B Dec/2025
ResMed USD 392.59M 44.06M Dec/2025
STAAR Surgical USD -18.31M 27.19M Dec/2025
Steris USD 192.9M 1000K Dec/2025
Stryker USD 849M 10M Dec/2025
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teleflex USD -714.33M 305.44M Dec/2025
Utah Medical Products USD 2.57M 445K Dec/2025
Zimmer Biomet Holdings USD 139.3M 91.6M Dec/2025